Shanghai Fosun Pharmaceutical | Cash Flow
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,028
2,983
3,541
3,764
4,134
3,577
Depreciation, Depletion & Amortization
532
710
811
864
1,091
1,595
Other Funds
1,118
1,100
1,199
2,008
1,501
405
Funds from Operations
2,150
2,408
2,532
3,254
3,753
4,593
Changes in Working Capital
519
612
92
296
161
459
Net Operating Cash Flow
1,631
1,797
2,441
2,959
3,592
4,134
Capital Expenditures
1,312
1,409
1,524
2,246
2,503
Sale of Fixed Assets & Businesses
46
275
572
601
1,258
Purchase/Sale of Investments
459
824
1,463
380
1,741
Net Investing Cash Flow
2,565
5,106
2,640
2,810
12,394
Cash Dividends Paid - Total
594
785
798
865
1,007
Issuance/Reduction of Debt, Net
497
3,733
2,568
500
10,259
Net Financing Cash Flow
1,215
4,047
571
1,642
10,753
Net Change in Cash
2,188
749
417
1,884
1,751
Free Cash Flow
318
388
917
713
1,089
Deferred Taxes & Investment Tax Credit
463
87
34
41
85
175
Net Assets from Acquisitions
2,808
3,259
301
773
9,490
Other Sources
2,042
518
118
50
147
Change in Capital Stock
-
-
-
-
-
Exchange Rate Effect
40
11
45
94
199
Other Uses
73
406
41
63
66
About Shanghai Fosun Pharmaceutical
View Profile
